LAUR

Laureate Education, Inc. Reports Q1 2025 Financial Results with Revenue Decrease and Adjusted EBITDA Decline

Laureate Education reported a net loss of $19.6 million in Q1 2025, amid fluctuating enrollments and calendar timing effects.

Quiver AI Summary

Laureate Education, Inc. reported its financial results for the first quarter of 2025, highlighting a decrease in new enrollments by 2%, although total enrollments increased by 4% when adjusted for the timing of semester start dates. Revenue fell 14% to $236.2 million, influenced by $26 million in calendar timing effects. The company faced an operating loss of $13.2 million compared to a profit of $11.1 million in the previous year, and a net loss of $19.6 million versus a $10.8 million loss in Q1 2024. Adjusted EBITDA also dropped significantly to $5.4 million from $30.6 million. Despite these challenges, CEO Eilif Serck-Hanssen expressed confidence in the recovery of enrollment and revenue, adjusting the full-year 2025 guidance upward based on improved visibility. He emphasized the organization's dedication to expanding access to quality education and highlighted the community impact of Laureate's institutions.

Potential Positives

  • New enrollments adjusted for timing showed a 7% increase, indicating strong demand during the main intake cycles in Peru and Mexico.
  • Laureate tightened its full-year 2025 guidance, raising the midpoint for both revenue and Adjusted EBITDA, reflecting increased visibility and confidence in future performance.
  • The company reaffirmed its commitment to return excess capital to shareholders, supported by its strong balance sheet and cash-accretive business model.
  • The recent annual Impact Report underscores Laureate's commitment to expanding access to quality higher education and positively influencing communities, reinforcing its brand value.

Potential Negatives

  • New enrollments decreased by 2%, indicating potential challenges in attracting new students.
  • Operating loss of $(13.2) million and a net loss of $(19.6) million for Q1 2025 represent a significant decline in financial performance compared to the previous year.
  • Adjusted EBITDA fell to $5.4 million, down 82% compared to Q1 2024, raising concerns about profitability and operational efficiency.

FAQ

What were Laureate Education's financial results for Q1 2025?

Laureate reported a revenue decrease of 14%, with a net loss of $19.6 million compared to $10.8 million in Q1 2024.

How did enrollment figures change in Q1 2025?

New enrollments decreased by 2%, while total enrollments increased by 4%, highlighting a strong intake cycle in Peru and Mexico.

What factors impacted Laureate's revenue for Q1 2025?

Revenue was negatively affected by $26 million due to intra-year academic calendar timing from later semester start dates compared to Q1 2024.

How is Laureate Education preparing for 2025?

Laureate tightened its 2025 guidance, raising the mid-point for revenue and Adjusted EBITDA due to improved enrollment visibility.

What is Laureate's overall outlook for the remainder of 2025?

Laureate expects continued growth in total enrollments, aiming for 491,000 to 495,000 students by year-end amidst economic uncertainty.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


$LAUR Insider Trading Activity

$LAUR insiders have traded $LAUR stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $LAUR stock by insiders over the last 6 months:

  • IAN KENDELL SNOW sold 520,831 shares for an estimated $9,098,917
  • MARCELO CARDOSO (CHIEF OPERATING OFFICER) has made 0 purchases and 3 sales selling 26,659 shares for an estimated $493,100.
  • CORRO PEDRO DEL sold 25,000 shares for an estimated $489,499
  • GERARD M. KNAUER (VP, ACCTG, GLOBAL CONTROLLER) sold 1,250 shares for an estimated $24,082

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LAUR Hedge Fund Activity

We have seen 118 institutional investors add shares of $LAUR stock to their portfolio, and 91 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release



MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico and Peru, today announced financial results for the first quarter and three months ended March 31, 2025.





First Quarter 2025




Highlights (compared to first quarter 2024):





  • New enrollments decreased 2%, up 7% adjusted for the timing of semester start dates.


  • Total enrollments increased 4%, up 6% adjusted for the timing of semester start dates.


  • On a reported basis, revenue decreased 14% to $236.2 million. On an organic constant currency basis

    1

    , revenue decreased 1% and was unfavorably affected by approximately $26 million of intra-year academic calendar timing attributable to later semester start dates in the first quarter of 2025 as compared to the first quarter of 2024.


  • Operating loss for the first quarter of 2025 was $(13.2) million, compared to operating income of $11.1 million for the first quarter of 2024.


  • Net loss for the first quarter of 2025 was $(19.6) million, compared to a net loss of $(10.8) million for the first quarter of 2024.


  • Adjusted EBITDA for the first quarter (seasonally low quarter) of 2025 was $5.4 million, compared to Adjusted EBITDA of $30.6 million for the first quarter of 2024. Adjusted EBITDA in the first quarter of 2025 was unfavorably affected by approximately $23 million of intra-year academic calendar timing attributable to later semester start dates in the first quarter of 2025 as compared to the first quarter of 2024.


  • Laureate expects that a majority of the first quarter intra-year academic calendar timing impacts on revenue and Adjusted EBITDA will be offset in the second half of the year.



Eilif Serck-Hanssen, President and Chief Executive Officer, said, “We are pleased to report favorable new enrollment results during the recently completed main intake cycle in Peru and secondary intake cycle in Mexico, further reinforcing the resiliency of our business model. With increased visibility into the remainder of the year, we are tightening the range on our full-year 2025 guidance, raising the mid-point for both Revenue and Adjusted EBITDA. We remain confident in the growing demand for quality higher education in both Mexico and Peru even in a time of economic uncertainty, driven by rising participation rates and the significant wage premium earned by graduates. With our leading brands and strong digital capabilities

,

we are ideally positioned to capitalize on those growth opportunities. In addition, we remain committed to continuing to return excess capital to shareholders, supported by a strong balance sheet and our cash-accretive business model.”



Mr. Serck-Hanssen added, “I am also proud to share that we published our annual Impact Report last month, highlighting the meaningful difference we make in the lives of millions by expanding access to quality higher education and serving as a vital part of our communities. This impact would not be possible without our team of more than 30,000 dedicated faculty and staff who embody our values every day. Their collective effort and unwavering commitment to our mission are the foundation of our continued success.”




1

Organic constant currency results exclude the period-over-period impact from currency fluctuations, acquisitions and divestitures.




First Quarter 2025




Results




New enrollments for the first quarter of 2025 decreased 2%, compared to new enrollment activity for the first quarter of 2024, and total enrollments were up 4% compared to the prior-year quarter. Adjusted for the timing of semester start dates, new and total enrollments increased 7% and 6%, respectively, through the completion of the intake cycles.



Timing adjusted new enrollments in Peru increased 6% during the primary intake as compared to the comparable period in the prior-year, and total enrollment grew 5%. In Mexico, new and total enrollments were up 8% and 7% during the secondary intake, respectively, compared to the prior-year intake period.



For the first quarter of 2025, revenue on a reported basis was $236.2 million, a decrease of $39.2 million, or 14%, compared to the first quarter of 2024. On an organic constant currency basis, revenue decreased 1% and was unfavorably affected by approximately $26 million of intra-year academic calendar timing attributable to later semester start dates in the first quarter of 2025 as compared to the first quarter of 2024. Operating loss for the first quarter of 2025 was $(13.2) million, compared to operating income of $11.1 million for the first quarter of 2024, a change of $24.3 million, mainly driven by the unfavorable effect of intra-year academic calendar timing of semester start dates combined with the weakening of the Mexican peso compared to the first quarter of 2024. Net loss for the first quarter of 2025 was $(19.6) million, compared to net loss of $(10.8) million for the first quarter of 2024. Basic and diluted loss per share for the first quarter of 2025 were $(0.13) as compared to $(0.07) for the first quarter of 2024.



Adjusted EBITDA for the first quarter of 2025 was $5.4 million, compared to Adjusted EBITDA of $30.6 million for the first quarter of 2024. Adjusted EBITDA in the first quarter of 2025 was unfavorably affected by approximately $23 million of intra-year academic calendar timing attributable to later semester start dates in the first quarter of 2025 as compared to the first quarter of 2024.





Balance Sheet and Capital Structure




Laureate has a strong balance sheet position. As of March 31, 2025, Laureate had $109.8 million of cash and cash equivalents and gross debt of $114.6 million. Accordingly, net debt was $4.8 million as of March 31, 2025.



Laureate repurchased approximately $42 million of its common stock during the first quarter of 2025 under the existing $100 million stock repurchase program. As of March 31, 2025, the Company had approximately $56 million of share repurchase authorization remaining under its existing stock repurchase program.



As of March 31, 2025, Laureate had 148.8 million total shares outstanding.





Outlook for Fiscal 2025




Laureate is updating its 2025 outlook to reflect increased visibility following the completion of the recent enrollment intake cycles. Laureate is tightening the guidance range by increasing the low-end of operational expectations and flowing through the foreign currency benefit recognized in the first quarter. The resulting impacts to its 2025 guidance mid-point expectations are a 1,000 increase in total enrollments, an approximately $10 million increase in revenues and an approximately $5 million increase in Adjusted EBITDA.



On an as-reported basis, Laureate continues to expect an unfavorable translation impact from currency versus 2024 due to the weakening of the Mexican Peso in the second half of 2024.



Based on assumed foreign exchange spot rates

2

, Laureate now expects its full-year 2025 results to be as follows:




  • Total enrollments expected to be in the range of 491,000 to 495,000 students, reflecting growth of 4%-5% versus 2024;


  • Revenues expected to be in the range of $1,560 million to $1,575 million, reflecting growth of 0%-1% on an as-reported basis and growth of 6%-7% on an organic constant currency basis versus 2024, or 7%-8% growth excluding the impact from campus consolidations; and


  • Adjusted EBITDA expected to be in the range of $473 million to $480 million, reflecting growth of 5%-7% on an as-reported basis and 11%-13% on an organic constant currency basis versus 2024.



Reconciliations of forward-looking non-GAAP measures, specifically the 2025 Adjusted EBITDA outlook, to the relevant forward-looking GAAP measures are not being provided, as Laureate does not currently have sufficient data to accurately estimate the variables and individual adjustments for such outlooks and reconciliations. Due to this uncertainty, the Company cannot reconcile projected Adjusted EBITDA to projected net income without unreasonable effort.



Please see the “Forward-Looking Statements” section in this release for a discussion of certain risks related to this outlook.





Conference Call




Laureate will host anearnings conference calltoday at 8:30 am ET. Interested parties are invited to listen to theearnings callby registering at

https://bit.ly/LAURQ12025

to receive dial-in information. The webcast of the conference call, including replays, and a copy of this press release and the related slides will be made available through the Investor Relations section of Laureate’s website at

www.laureate.net

.




2

Based on actual FX rates for January-April 2025, and assumed spot FX rates (local currency per U.S. Dollar) of MXN 20.50 and PEN 3.71 for May 2025 - December 2025. FX impact may change based on fluctuations in currency rates in future periods.





Forward-Looking Statements




This press release includes statements that express Laureate’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, ‘‘forward-looking statements’’ within the meaning of the federal securities laws, which involve risks and uncertainties. Laureate’s actual results may vary significantly from the results anticipated in these forward-looking statements. You can identify forward-looking statements because they contain words such as ‘‘believes,’’ ‘‘expects,’’ ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘seeks,’’ ‘‘approximately,’’ ‘‘intends,’’ ‘‘plans,’’ ‘‘estimates’’ or ‘‘anticipates’’ or similar expressions that concern our strategy, plans or intentions. In particular, statements regarding the amount, timing, process, tax treatment and impact of any future dividends represent forward-looking statements. All statements we make relating to guidance (including, but not limited to, total enrollments, revenues, and Adjusted EBITDA), and all statements we make relating to our current growth strategy and other future plans, strategies or transactions that may be identified, explored or implemented and any litigation or dispute resulting from any completed transaction are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. All of these forward-looking statements are subject to risks and uncertainties that may change at any time, including with respect to our current growth strategy and the impact of any completed divestiture or separation transaction on our remaining businesses. Accordingly, our actual results may differ materially from those we expected. We derive most of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations are disclosed in our Annual Report on Form 10-K filed with the SEC on February 20, 2025, our subsequent Quarterly Reports on Form 10-Q filed, and to be filed, with the SEC and other filings made with the SEC. These forward-looking statements speak only as of the time of this release and we do not undertake to publicly update or revise them, whether as a result of new information, future events or otherwise, except as required by law.





Presentation of Non-GAAP Measures




In addition to the results provided in accordance with U.S. generally accepted accounting principles (GAAP) throughout this press release, Laureate provides the non-GAAP measurements of Adjusted EBITDA, Adjusted net income, Adjusted earnings per share (Adjusted EPS), and total debt, net of cash and cash equivalents (or net debt). We have included the non-GAAP measures of Adjusted EBITDA and net debt because they are key measures used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short- and long-term operational plans. We have included the non-GAAP measures of Adjusted net income and Adjusted EPS because management believes that these measures provide investors with better visibility into the Company’s underlying earnings as they exclude items that may not be indicative of our core operating results.



Adjusted EBITDA consists of net income (loss), before (income) loss from discontinued operations, net of tax, equity in net (income) loss of affiliates, net of tax, income tax expense (benefit), (gain) loss on disposal of subsidiaries, net, foreign currency exchange (gain) loss, net, other (income) expense, net, interest expense, interest income, and loss on debt extinguishment,

plus

depreciation and amortization, share-based compensation expense, and loss on impairment of assets. The exclusion of certain expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business. Additionally, Adjusted EBITDA is a key input into the formula used by the compensation committee of our board of directors and our Chief Executive Officer in connection with the payment of incentive compensation to our executive officers and other members of our management team. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.



We define Adjusted net income as net income (loss), before (income) loss from discontinued operations, plus discrete tax items, loss on debt extinguishment, loss (gain) on disposal of subsidiaries, net, foreign currency exchange (gain) loss, net, and loss on impairment of assets. We define Adjusted EPS as Adjusted net income divided by GAAP diluted weighted average shares outstanding. Adjusted net income and Adjusted EPS provide a useful indicator about Laureate’s earnings from core operations.



Total debt, net of cash and cash equivalents (or net debt) consists of total gross debt, less total cash and cash equivalents. Net debt provides a useful indicator about Laureate’s leverage and liquidity.



Free Cash Flow consists of operating cash flow minus capital expenditures (net of sales of PP&E). Free Cash Flow provides a useful indicator about Laureate’s ability to fund its operations and repay its debt.



Adjusted EBITDA to Unlevered Free Cash Flow Conversion consists of Unlevered Free Cash Flow (which is defined as cash flows from operating activities, less capital expenditures (net of sales of PP&E), plus net cash interest expense) divided by Adjusted EBITDA. Adjusted EBITDA to Unlevered Free Cash Flow provides useful information to investors and others in understanding and evaluating our ability to generate cash flows.



Laureate’s calculations of Adjusted EBITDA, Adjusted net income, Adjusted EPS, and total debt, net of cash and cash equivalents (or net debt) are not necessarily comparable to calculations performed by other companies and reported as similarly titled measures. These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP but should not be considered a substitute for or superior to GAAP results. Adjusted EBITDA, Adjusted net income and Adjusted EPS are reconciled from their most directly comparable GAAP measures in the attached tables under “Non-GAAP Reconciliations.”



We evaluate our results of operations on both an as reported and an organic constant currency basis. The organic constant currency presentation, which is a non-GAAP measure, excludes the impact of fluctuations in foreign currency exchange rates, acquisitions and divestitures. We believe that providing organic constant currency information provides valuable supplemental information regarding our results of operations, consistent with how we evaluate our performance. We calculate organic constant currency amounts using the change from prior-period average foreign exchange rates to current-period average foreign exchange rates, as applied to local-currency operating results for the current period, and then exclude the impact of acquisitions and divestitures.




About Laureate Education, Inc.




Laureate Education, Inc.


operates five higher education institutions across Mexico and Peru, enrolling more than 470,000 students in high-quality undergraduate, graduate, and specialized degree programs through campus-based and online learning. Our universities have a deep commitment to academic quality and innovation, strive for market-leading employability outcomes, and work to make higher education more accessible. At Laureate, we know that when our students succeed, countries prosper, and societies benefit. Learn more at laureate.net.




Key Metrics and Financial Tables




(Dollars in millions, except per share amounts, and may not sum due to rounding)



New and Total Enrollments by segment

































































































































New Enrollments




Total Enrollments








Change








Change




YTD 1Q 2025




YTD 1Q 2024




Total




Timing




Adj.

(1)





As of 03/31/2025




As of 03/31/2024




Total




Timing




Adj.

(1)



Mexico

44,200


41,100


8

%


8

%


250,200


233,700


7

%


7

%

Peru

49,800


54,500


(9)%


6

%


226,800


225,700




%


5

%


Laureate


94,000


95,600


(2)%


7

%


477,000


459,400


4

%


6

%























(1)

Adjusted for the timing of semester start dates



Consolidated Statements of Operations




































































































































































































































































































































For the three months ended March 31,



IN MILLIONS (except per share amounts)




2025






2024





Change



Revenues


$

236.2



$

275.4



$

(39.2

)

Costs and expenses:






Direct costs


238.4




254.0




(15.6

)

General and administrative expenses


11.0




10.3




0.7



Operating (loss) income



(13.2

)



11.1




(24.3

)

Interest income


1.5




1.9




(0.4

)

Interest expense


(2.4

)



(4.7

)



2.3


Other expense, net







(0.5

)



0.5


Foreign currency exchange loss, net


(3.2

)



(5.6

)



2.4


Loss on disposal of subsidiaries, net







(3.1

)



3.1


Loss from continuing operations before income taxes


(17.3

)



(0.9

)



(16.4

)

Income tax expense


(2.5

)



(9.9

)



7.4



Loss from continuing operations



(19.8

)



(10.8

)



(9.0

)

Income (loss) from discontinued operations, net of tax


0.2




(0.1

)



0.3



Net loss



(19.6

)



(10.8

)



(8.8

)

Net loss attributable to noncontrolling interests


0.1




0.1








Net loss attributable to Laureate Education, Inc.


$

(19.5

)


$

(10.8

)


$

(8.7

)














Basic and diluted earnings (loss) per share:













Basic and diluted weighted average shares outstanding


147.6




157.0




(9.4

)

Basic and diluted loss per share

$

(0.13

)


$

(0.07

)


$

(0.06

)














Revenue and Adjusted EBITDA by segment




IN MILLIONS























































































































































































































































































































































































% Change




$ Variance Components



For the three months ended March 31,




2025






2024





Reported




Organic Constant




Currency

(2)





Total




Organic Constant




Currency




Acq/Div.




FX



Revenues

















Mexico

$

189.3



$

214.1



(12

)%


6

%


$

(24.8

)


$

13.6



$




$

(38.4

)

Peru


46.9




61.2



(23

)%


(25

)%



(14.3

)



(15.1

)







0.8


Corporate & Eliminations


0.1








nm



nm




0.1




0.1












Total Revenues


$

236.2



$

275.4



(14

)%


(1

)%


$

(39.2

)


$

(1.6

)


$




$

(37.6

)


















Adjusted EBITDA

















Mexico

$

53.0



$

59.9



(12

)%


7

%


$

(6.9

)


$

4.2



$




$

(11.1

)

Peru


(38.8

)



(20.7

)


(87

)%


(86

)%



(18.1

)



(17.7

)







(0.4

)

Corporate & Eliminations


(8.8

)



(8.6

)


(2

)%


(2

)%



(0.2

)



(0.2

)











Total Adjusted EBITDA


$

5.4



$

30.6



(82

)%


(45

)%


$

(25.2

)


$

(13.7

)


$




$

(11.5

)
































nm - percentage changes not meaningful





(2)

Organic Constant Currency results exclude the period-over-period impact from currency fluctuations, acquisitions and divestitures. Organic Constant Currency is calculated using the change from prior-period average foreign exchange rates to current-period average foreign exchange rates, as applied to local-currency operating results for the current period. The “Organic Constant Currency” percentage changes are calculated by dividing the Organic Constant Currency amounts by the 2024 Revenues and Adjusted EBITDA amounts, excluding the impact of the divestitures.



Consolidated Balance Sheets

































































































































































































































































































IN MILLIONS



March 31, 2025




December 31, 2024




Change



Assets







Cash and cash equivalents

$

109.8


$

91.4


$

18.4


Receivables (current), net


47.4



91.8



(44.4

)

Other current assets


69.9



43.6



26.3


Property and equipment, net


522.0



514.3



7.7


Operating lease right-of-use assets, net


282.1



292.4



(10.3

)

Goodwill and other intangible assets


714.7



711.3



3.4


Deferred income taxes


56.6



60.8



(4.2

)

Other long-term assets


45.1



45.6



(0.5

)

Current and long-term assets held for sale


10.6



11.0



(0.4

)


Total assets


$

1,858.2


$

1,862.1


$

(3.9

)








Liabilities and stockholders' equity







Accounts payable and accrued expenses

$

181.5


$

187.6


$

(6.1

)

Deferred revenue and student deposits


112.5



64.3



48.2


Total operating leases, including current portion


321.3



327.1



(5.8

)

Total long-term debt, including current portion


112.9



100.3



12.6


Other liabilities


213.1



214.5



(1.4

)

Current and long-term liabilities held for sale


9.5



9.7



(0.2

)


Total liabilities



950.8



903.5



47.3


Redeemable equity


1.4



1.4







Total stockholders' equity



906.0



957.1



(51.1

)


Total liabilities and stockholders' equity


$

1,858.2


$

1,862.1


$

(3.9

)












Consolidated Statements of Cash Flows
















































































































































































































































































































































































For the three months ended March 31,



IN MILLIONS




2025






2024





Change



Cash flows from operating activities







Net loss

$

(19.6

)


$

(10.8

)


$

(8.8

)

Depreciation and amortization


16.1




18.1




(2.0

)

(Gain) loss on lease terminations and disposals of subsidiaries and property and equipment, net


(0.3

)



3.3




(3.6

)

Deferred income taxes


4.9




1.3




3.6


Unrealized foreign currency exchange loss


2.9




5.0




(2.1

)

Income tax receivable/payable, net


(20.9

)



(12.0

)



(8.9

)

Working capital, excluding tax accounts


56.0




7.4




48.6


Other non-cash adjustments


18.7




21.0




(2.3

)


Net cash provided by operating activities



57.8




33.2




24.6



Cash flows from investing activities







Purchase of property and equipment


(4.6

)



(15.9

)



11.3


Receipts from sales of property and equipment


0.1









0.1


Payments related to sales of discontinued operations







(0.2

)



0.2



Net cash used in investing activities



(4.6

)



(16.0

)



11.4



Cash flows from financing activities







Increase in long-term debt, net


7.5




54.5




(47.0

)

Payments to repurchase common stock


(39.5

)



(32.9

)



(6.6

)

Financing other, net


(2.7

)



(3.3

)



0.6



Net cash (used in) provided by financing activities



(34.6

)



18.4




(53.0

)

Effects of exchange rate changes on Cash and cash equivalents and Restricted cash


0.9




1.1




(0.2

)

Change in cash included in current assets held for sale


(0.4

)



0.3




(0.7

)


Net change in Cash and cash equivalents and Restricted cash



19.1




36.9




(17.8

)

Cash and cash equivalents and Restricted cash at beginning of period


97.9




96.9




1.0



Cash and cash equivalents and Restricted cash at end of period


$

116.9



$

133.8



$

(16.9

)














Non-GAAP Reconciliation (1 of 2)



The following table reconciles Net loss to Adjusted EBITDA:
















































































































































































































































































For the three months ended March 31,



IN MILLIONS




2025






2024





Change



Net loss


$

(19.6

)


$

(10.8

)


$

(8.8

)

Plus:






(Income) loss from discontinued operations, net of tax


(0.2

)



0.1




(0.3

)

Loss from continuing operations


(19.8

)



(10.8

)



(9.0

)

Plus:






Income tax expense


2.5




9.9




(7.4

)

Loss from continuing operations before income taxes


(17.3

)



(0.9

)



(16.4

)

Plus:






Loss on disposal of subsidiaries, net







3.1




(3.1

)

Foreign currency exchange loss, net


3.2




5.6




(2.4

)

Other expense, net







0.5




(0.5

)

Interest expense


2.4




4.7




(2.3

)

Interest income


(1.5

)



(1.9

)



0.4


Operating (loss) income


(13.2

)



11.1




(24.3

)

Plus:






Depreciation and amortization


16.1




18.1




(2.0

)

EBITDA


2.9




29.2




(26.3

)

Plus:






Share-based compensation expense

(3)



2.5




1.4




1.1


Adjusted EBITDA

$

5.4



$

30.6



$

(25.2

)




(3)

Represents non-cash, share-based compensation expense pursuant to the provisions of ASC Topic 718, "Stock Compensation."



Non-GAAP Reconciliations (2 of 2)



The following table reconciles Net loss to Adjusted net loss and Adjusted EPS:












































































































































































































































For the three months ended March 31,





2025






2024




IN MILLIONS, except per share amounts





(per share)

(4)







(per share)

(4)



Net loss

$

(19.6

)


$

(0.13

)


$

(10.8

)


$

(0.07

)

Plus:








(Income) loss from discontinued operations, net of tax


(0.2

)








0.1







Loss from continuing operations


(19.8

)



(0.13

)



(10.8

)



(0.07

)

Plus:








Discrete tax items




















Loss on debt extinguishment




















Loss on disposal of subsidiaries, net












3.1




0.02


Foreign currency exchange loss, net


3.2




0.02




5.6




0.04


Loss on impairment of assets




















Adjusted net loss

$

(16.6

)


$

(0.11

)


$

(2.1

)


$

(0.01

)









Diluted weighted average shares outstanding




147.6






157.0





(4)

Per share amounts on a dilutive basis








Investor Relations Contact:





ir@laureate.net





Media Contacts:






























Laureate Education




Adam Smith




adam.smith@laureate.net




U.S.: +1 (443) 255 0724



Source: Laureate Education, Inc.







This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.